| Renal Medullary Carcinoma studied in …STUDIED_INderived11 of 11show fewer |
|---|
| → studied in | NCT07816770Phase 2 · not yet recruiting MANTIS-RCC: Toripalimab-Axitinib Induction in TLS-Positive Advanced Non-Clear Cell and Renal Medullary Carcinomas · condition mapped CURATED_BROADER · 11 trials mapped (5 active) | — | — | Renal Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06161532Phase 2 · recruiting Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C... · condition mapped ONTOLOGY_EXACT · 11 trials mapped (5 active) | — | — | Renal Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06444880Phase 2 · active not recruiting Phase II Trial of Ubamatamab Alone or in Combination With Cemiplimab in MUC16-Expressing SMARCB1-Deficient Malignancies · condition mapped ONTOLOGY_EXACT · 11 trials mapped (5 active) | — | — | Renal Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03874455no longer available Tazemetostat Expanded Access Program for Adults With Solid Tumors · condition mapped ONTOLOGY_EXACT · 11 trials mapped (5 active) | — | — | Renal Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05347212Phase 2 · active not recruiting Phase II Trial of Immunotherapy in Patients With Carcinomas Arising From the Renal Medulla · condition mapped ONTOLOGY_EXACT · 11 trials mapped (5 active) | — | — | Renal Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07502716available Compassionate Use of Ubamatamab · condition mapped ONTOLOGY_EXACT · 11 trials mapped (5 active) | — | — | Renal Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02875548Phase 1/Phase 2 · completed A Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical Study · condition mapped ONTOLOGY_EXACT · 11 trials mapped (5 active) | — | — | Renal Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06302569Phase 2 · recruiting Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma · condition mapped ONTOLOGY_EXACT · 11 trials mapped (5 active) | — | — | Renal Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02601950Phase 2 · completed A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 11 trials mapped (5 active) | — | — | Renal Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04537715Phase 1 · completed Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels · condition mapped ONTOLOGY_EXACT · 11 trials mapped (5 active) | — | — | Renal Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00027820Phase 1/Phase 2 · completed Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer · condition mapped ONTOLOGY_EXACT · 11 trials mapped (5 active) | — | — | Renal Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |